. "Appendix D: Chronology of Important Events Regarding Vaccine Safety." Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press, 2004.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Immunization Safety Review: Vaccines and Autism
Year
Vaccine Licensure
Legislation and/or Policy Statements
IOM Reports on Vaccine Safety
1999
ACIP updates varicella vaccine recommendation, requiring immunity for child care and school entry
ACIP recommends an all-IPV schedule to begin January 2000 to prevent cases of vaccine-associated paralytic polio
AAP and PHS recommend removal of thimerosal from vaccines Also recommended postponement of hepatitis B vaccine from birth to 2-6 months for infants of hepatitis B surface antigen-negative mothers
Additional supply of thimerosal-free hepatitis B vaccine made available
MMWR notifies readers of the availability of a thimerosal-free hepatitis B vaccine, enabling the resumption of the birth dose
2000
Pneumococcal vaccine for infants and young children licensed (Prevnar)
ACIP recommends pneumococcal vaccination for all children 2-23 months, and at-risk children 24-59 months (e.g., immunocompromised)
2001
October: ACIP drafts statement expressing a preference for use of thimerosal-free DTaP, Hib, and Hep B vaccines by March 2002
Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism
Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders
